EGFR and lung carcinoma: Germ-line polymorphisms for EGF, EGFR, Cox2, Cyclin D1, and FCGR2A may also be significant predictive markers for treatment response in lung cancer [57], but data from patients with cervical tumours treated with EGFR inhibitors is critically needed.